NTRC Competitors and Similar CompaniesClear all
NTRC's competitors and similar companies include Nektar Therapeutics, AVEO Pharmaceuticals, Candel Therapeutics and Captor Therapeutics.
 NTRC NTRC (Netherlands Translational Research Center) is a precision medicine biotech company dedicated to the development of anti-cancer drugs. |  AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  Captor Therapeutics Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 1990 | Founding Date 2001 | Founding Date 1999 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Oss, NL HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Boston, US HQ | Locations Needham, US HQ | Locations Wrocław, PL HQ Allschwil, CH |
Employees | Employees 2 | Employees 61821% increase | Employees 1912% increase | Employees 50 | Employees 88 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 515.6 m | Valuation ($) 176.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $42.3m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income ($53.3m) (FY, 2021) | Net income ($38.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 60.7k | Total funding raised $ 45m | Total funding raised $ 224m | Total funding raised $ 64.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyAVEO Pharmaceuticals
HQ
Boston, US
Employees
19↑ 12% increase
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View companyCaptor Therapeutics
HQ
Wrocław, PL
Employees
88
Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases.
View company